XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.19.1

8. Earnings Per Share | 3 Months Ended
--- | ---
Mar. 31, 2019
Earnings Per Share [Abstract] |
Earnings Per Share | . EARNINGS PER SHARE Basic earnings per share is computed by dividing net income attributable to Bio-Rad by the weighted average number of common shares outstanding for that period. Diluted earnings per share takes into account the effect of dilutive instruments, such as stock options and restricted stock, and uses the average share price for the period in determining the number of potential common shares that are to be added to the weighted average number of shares outstanding. Potential common shares are excluded from the diluted earnings per share calculation if the effect of including such securities would be anti-dilutive. The weighted average number of common shares outstanding used to calculate basic and diluted earnings per share, and the anti-dilutive shares that are excluded from the diluted earnings per share calculation are as follows (in thousands):
| Three Months Ended
| March 31,
| 2019 |  | 2018
Basic weighted average shares outstanding | 29,801 |  |  | 29,787 |
Effect of potentially dilutive stock options and restricted stock awards | 303 |  |  | 384 |
Diluted weighted average common shares | 30,104 |  |  | 30,171 |
Anti-dilutive shares | 226 |  |  | 41 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration